Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Net Income: 2020-2025

Historic Net Income for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$45.1 million.

  • Maravai Lifesciences Holdings' Net Income rose 73.87% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 33.91%. This contributed to the annual value of -$259.6 million for FY2024, which is 87.62% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Net Income stood at -$45.1 million, which was up 35.48% from -$69.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Net Income ranged from a high of $156.7 million in Q2 2022 and a low of -$172.5 million during Q3 2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Net Income averaged around -$51.4 million, with its median value being -$45.1 million (2025).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Net Income surged by 9,227.12% in 2021 and then plummeted by 1,582.49% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Net Income (Quarterly) stood at $127.1 million in 2021, then crashed by 31.22% to $87.4 million in 2022, then crashed by 225.80% to -$110.0 million in 2023, then skyrocketed by 58.11% to -$46.1 million in 2024, then soared by 73.87% to -$45.1 million in 2025.
  • Its Net Income stands at -$45.1 million for Q3 2025, versus -$69.8 million for Q2 2025 and -$52.9 million for Q1 2025.